Puma – PHARMA
PumaBiotech (@pumabiotech) / Twitter
El negocio bursátil de PUMA BIOTECHNOLOGY – Observatorio de biopolitica
Puma Biotechnology
Puma Biotechnology
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
Exhibitor Puma Biotechnology 11-6 - Scripps CME Connection
Puma Men – PHARMA
Puma Biotechnology
Resumen: Puma Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y comercializar NERLYNX® (neratinib) en Europa | Business Wire
Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking Alpha
Puma Pharma (@PumaPharma) / Twitter
Puma – PHARMA
Puma Biotechnology
PUMA BIOTECHNOLOGY, INC. : Precios y cotizaciones Acción | PBYI | US74587V1070 | MarketScreener
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
Puma Biotechnology, Inc. | LinkedIn
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
PHARMA JONPI .: 08/24/14
Puma Biotechnology Surging
Puma – PHARMA
PharmaBg
Puma – PHARMA
Medical Affairs eLearning - MSL Society
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
